Excision BioTherapeutics Completes $60 Million Financing to Advance CRISPR-Based Infectious Disease Programs

NEXT STORY
SCYNEXIS Announces Licensing Agreement and Strategic Partnership with Hansoh Pharma for Rights to Ibrexafungerp in Greater China
PREV STORY
Global Blood Culture Tests Market (2020 to 2025) – Identification of Antibiotic-Resistant Microorganisms Presents Opportunities
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BOON Completes Phase-I of EPA Testing of DIOX+ $25M Revenue on Horizon

author_avatar
NASDAQ Market News

Signature Resources Commences Drilling at its 100% Owned Lingman Lake Gold Project

author_avatar
NASDAQ Market News

Genkyotex Annonce Les Résultats Favorables de L’analyse Post-Hoc de L’essai de Phase 2 Dans la CBP et Publie sa Situation de Trésorerie au 30 Juin 2019

author_avatar
NASDAQ Market News